Compare FBIO & RSSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FBIO | RSSS |
|---|---|---|
| Founded | 2006 | 2006 |
| Country | United States | United States |
| Employees | 101 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 104.6M | 93.7M |
| IPO Year | N/A | 2008 |
| Metric | FBIO | RSSS |
|---|---|---|
| Price | $2.47 | $2.36 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $17.00 | $5.00 |
| AVG Volume (30 Days) | ★ 423.6K | 38.6K |
| Earning Date | 03-31-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 130.77 |
| EPS | N/A | ★ 0.04 |
| Revenue | N/A | ★ $28,793,922.00 |
| Revenue This Year | $29.71 | $1.81 |
| Revenue Next Year | $49.34 | $5.73 |
| P/E Ratio | ★ N/A | $56.50 |
| Revenue Growth | N/A | ★ 2.77 |
| 52 Week Low | $1.33 | $2.15 |
| 52 Week High | $4.53 | $4.12 |
| Indicator | FBIO | RSSS |
|---|---|---|
| Relative Strength Index (RSI) | 30.65 | 53.62 |
| Support Level | $2.47 | $2.16 |
| Resistance Level | $2.71 | $2.94 |
| Average True Range (ATR) | 0.17 | 0.10 |
| MACD | -0.04 | 0.02 |
| Stochastic Oscillator | 1.36 | 85.19 |
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.
Research Solutions Inc is a holding company. The company provides vertical software-as-a-service ("SaaS") and artificial intelligence ("AI") solutions, providing software and related services to help research-intensive organizations simplify the research process, save time, and money. The company operates in a single segment, which derives its revenue from subscription fees from its cloud-based SaaS Platforms and transactional service fees for the electronic delivery of single articles. The company generates the majority of its revenue from the Transactions. Geographically, the company generates the majority of its revenue from the United States, followed by Europe.